Cargando…
Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
The coronaviruses belong to the Coronaviridae family, and one such member, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing significant destruction around the world in the form of a global pandemic. Although vaccines have been developed, their effectiveness and level of prote...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025073/ https://www.ncbi.nlm.nih.gov/pubmed/35454354 http://dx.doi.org/10.3390/medicina58040515 |
_version_ | 1784690776921341952 |
---|---|
author | Alzamami, Ahmad Alturki, Norah A. Alghamdi, Youssef Saeed Ahmad, Shaban Alshamrani, Saleh Asiri, Saeed A. Mashraqi, Mutaib M. |
author_facet | Alzamami, Ahmad Alturki, Norah A. Alghamdi, Youssef Saeed Ahmad, Shaban Alshamrani, Saleh Asiri, Saeed A. Mashraqi, Mutaib M. |
author_sort | Alzamami, Ahmad |
collection | PubMed |
description | The coronaviruses belong to the Coronaviridae family, and one such member, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing significant destruction around the world in the form of a global pandemic. Although vaccines have been developed, their effectiveness and level of protection is still a major concern, even after emergency approval from the World Health Organisation (WHO). At the community level, no natural medicine is currently available as a cure. In this study, we screened the vast library from Drug Bank and identified Hemi-Babim and Fenoterol as agents that can work against SARS-CoV-2. Furthermore, we performed molecular dynamics (MD) simulation for both compounds with their respective proteins, providing evidence that the said drugs can work against the MPro and papain-like protease, which are the main drug targets. Inhibiting the action of these targets may lead to retaining the virus. Fenoterol is a beta-2 adrenergic agonist used for the symptomatic treatment of asthma as a bronchodilator and tocolytic. In this study, Hemi-Babim and Fenoterol showed good docking scores of −7.09 and −7.14, respectively, and performed well in molecular dynamics simulation studies. Re-purposing the above medications has huge potential, as their effects are already well-proven and under public utilisation for asthma-related problems. Hence, after the comprehensive pipeline of molecular docking, MMGBSA, and MD simulation studies, these drugs can be tested in-vivo for further human utilisation. |
format | Online Article Text |
id | pubmed-9025073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90250732022-04-23 Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study Alzamami, Ahmad Alturki, Norah A. Alghamdi, Youssef Saeed Ahmad, Shaban Alshamrani, Saleh Asiri, Saeed A. Mashraqi, Mutaib M. Medicina (Kaunas) Article The coronaviruses belong to the Coronaviridae family, and one such member, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is causing significant destruction around the world in the form of a global pandemic. Although vaccines have been developed, their effectiveness and level of protection is still a major concern, even after emergency approval from the World Health Organisation (WHO). At the community level, no natural medicine is currently available as a cure. In this study, we screened the vast library from Drug Bank and identified Hemi-Babim and Fenoterol as agents that can work against SARS-CoV-2. Furthermore, we performed molecular dynamics (MD) simulation for both compounds with their respective proteins, providing evidence that the said drugs can work against the MPro and papain-like protease, which are the main drug targets. Inhibiting the action of these targets may lead to retaining the virus. Fenoterol is a beta-2 adrenergic agonist used for the symptomatic treatment of asthma as a bronchodilator and tocolytic. In this study, Hemi-Babim and Fenoterol showed good docking scores of −7.09 and −7.14, respectively, and performed well in molecular dynamics simulation studies. Re-purposing the above medications has huge potential, as their effects are already well-proven and under public utilisation for asthma-related problems. Hence, after the comprehensive pipeline of molecular docking, MMGBSA, and MD simulation studies, these drugs can be tested in-vivo for further human utilisation. MDPI 2022-04-05 /pmc/articles/PMC9025073/ /pubmed/35454354 http://dx.doi.org/10.3390/medicina58040515 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Alzamami, Ahmad Alturki, Norah A. Alghamdi, Youssef Saeed Ahmad, Shaban Alshamrani, Saleh Asiri, Saeed A. Mashraqi, Mutaib M. Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title | Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title_full | Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title_fullStr | Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title_full_unstemmed | Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title_short | Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study |
title_sort | hemi-babim and fenoterol as potential inhibitors of mpro and papain-like protease against sars-cov-2: an in-silico study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025073/ https://www.ncbi.nlm.nih.gov/pubmed/35454354 http://dx.doi.org/10.3390/medicina58040515 |
work_keys_str_mv | AT alzamamiahmad hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT alturkinoraha hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT alghamdiyoussefsaeed hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT ahmadshaban hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT alshamranisaleh hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT asirisaeeda hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy AT mashraqimutaibm hemibabimandfenoterolaspotentialinhibitorsofmproandpapainlikeproteaseagainstsarscov2aninsilicostudy |